EQUITY TRANSACTIONS |
6 Months Ended |
|---|---|
Jun. 30, 2025 | |
| Equity [Abstract] | |
| EQUITY TRANSACTIONS |
NOTE 12 – EQUITY TRANSACTIONS
2025 Common Stock Transactions
During the six months ended June 30, 2025, the Company sold 200,000 shares of restricted common stock at $0.05 per share. Net proceeds were $9,000, after paying a 10% in transaction fees.
During the six months ended June 30, 2025, 4 million shares of preferred stock was converted into 3.6 million shares of common stock. As part of the transaction, $225,000 of debt was also contributed to paid in capital, as well as $8,600 in accrued interest on the debt.
2024 Common Stock Transactions
During the six months ended June 30, 2024, no new equity transactions have occurred.
Non-controlling Interest
The non-controlling interest presented in our condensed consolidated financial statements reflects a 46% non-controlling equity interest in PWS and 49% non-controlling equity interest in PelleChar. Net losses attributable to non-controlling interest, as reported on our condensed consolidated statements of operations, represents the net loss of each entity attributable to the non-controlling equity interest. The non-controlling interest is reflected within stockholders’ equity on the condensed consolidated balance sheet.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for equity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|